CDKN2A and coronary artery disorder: Notably, the CAD risk interval contains a cis-acting enhancer that collaborates with TGFβ to promote ARF expression during development (Zheng et al., 2013), and mice lacking the CAD interval don’t show such induction of ARF, implying that TGFβ works on ARF via the enhancers in CAD interval.